Page last updated: 2024-08-21

isoxazoles and Autoimmune Disease

isoxazoles has been researched along with Autoimmune Disease in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.71)18.7374
1990's14 (40.00)18.2507
2000's8 (22.86)29.6817
2010's10 (28.57)24.3611
2020's1 (2.86)2.80

Authors

AuthorsStudies
Chen, Y; He, C; Li, M; Liu, S; Wang, L; Wu, D; Yang, Y; Zeng, X; Zhang, F; Zheng, K1
Gao, D; Huang, F; Jin, J; Li, K; Luo, G; Wang, X; Wang, Y; Yang, C; Zhang, J; Zhao, Y; Zhao, Z; Zhu, J1
Fang, CB; He, Y; Huang, C; Li, J; Lin, Z; Zhan, SX; Zhou, DX1
Brooks, JB; Fragoso, YD1
Fang, C; He, Y; Huang, C; Li, J; Lin, Z; Zhan, S; Zhou, D1
Baker, TA; Colopy, SA; Muir, P1
Leban, J; Vitt, D1
Mishra, OP; Mittal, R; Prasad, R; Singh, UK1
Kiss, CG; Kiss, E; Poór, G1
Duan, K; Jin, D; Peng, J; Zhang, L; Zhao, Y1
Palazzo, E; Yahia, SA1
Frieling, U; Luger, TA1
Kushwaha, SS; Mayer, DF1
Kiely, PD1
Apostolski, S; Bartlett, RR; Damjanovic, M; Isakovic, K; Kosec, D; Vidic-Dankovic, B1
Lang, LS; Robertson, SM1
Anagnostopulos, H; Bartlett, RR; Mattar, T; Schleyerbach, R; Zielinski, T1
Brazelton, TR; Morris, RE1
Bartlett, RR; Brendel, S; Schorlemmer, HU; Zielinski, T1
Morris, RE; Silva Júnior, HT1
Blinder, L; Chong, AS; Finnegan, A; Gong, H; Shen, J; Williams, JW; Xu, X1
Bartlett, RR; Schorlemmer, HU2
Blinder, L; Chong, AS; Gong, H; Shen, J; Williams, JW; Xu, X1
Chong, AS; Foster, P; Guo, Z; Jensik, SC; McChesney, L; Mital, D; Sankary, H; Shen, J; Tian, Y; Williams, JW1
Colic, M; Dimitrijevic, M; Milenkovic, M; Milosavljevic, P1
Bartlett, R; Dimitrijevic, M; Stosic-Grujicic, S1
Herrmann, ML; Kirschbaum, BJ; Schleyerbach, R1
Schorlemmer, HU1
Fehr, T; Ochsenbein, AF; Pinschewer, DD; Zinkernagel, RM1
Harisdangkul, V; Sanders, S1
Pfeiffer, C; Wozel, G1
Bartlett, RR; Bremer, E; Dimitrijevic, M; Germann, T; Küchle, CC; Mattar, T; Rüde, E; Schorlemmer, HU; Thoenes, GH; Zielinski, T1
Bartlett, RR; Langer, KH; Schleyerbach, R; Sitter, T; Thoenes, GH1
Bartlett, RR; Popovic, S1

Reviews

19 review(s) available for isoxazoles and Autoimmune Disease

ArticleYear
Leflunomide: Traditional immunosuppressant with concurrent antiviral effects.
    International journal of rheumatic diseases, 2023, Volume: 26, Issue:2

    Topics: Antiviral Agents; Autoimmune Diseases; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide

2023
Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review.
    Internal medicine journal, 2017, Volume: 47, Issue:6

    Topics: Autoimmune Diseases; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Remission Induction; Retrospective Studies; Treatment Outcome

2017
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
    Expert review of clinical pharmacology, 2015, Volume: 8, Issue:3

    Topics: Animals; Autoimmune Diseases; Crotonates; Humans; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Nitriles; Pyrimidines; T-Lymphocytes; Toluidines

2015
Human dihydroorotate dehydrogenase inhibitors, a novel approach for the treatment of autoimmune and inflammatory diseases.
    Arzneimittel-Forschung, 2011, Volume: 61, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Autoimmune Diseases; Dihydroorotate Dehydrogenase; Drug Design; Enzyme Inhibitors; Humans; Inflammation; Isoxazoles; Leflunomide; Oxidoreductases Acting on CH-CH Group Donors; Randomized Controlled Trials as Topic; Structure-Activity Relationship

2011
Immunosuppressive therapy in children.
    Journal of the Indian Medical Association, 2011, Volume: 109, Issue:2

    Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus

2011
[Systemic autoimmune disorders and pregnancy].
    Orvosi hetilap, 2011, Oct-23, Volume: 152, Issue:43

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha

2011
Progressive multifocal leukoencephalopathy in autoimmune diseases.
    Joint bone spine, 2012, Volume: 79, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Comorbidity; Drug Therapy, Combination; Glucocorticoids; Humans; Infliximab; Isoxazoles; JC Virus; Leflunomide; Leukoencephalopathy, Progressive Multifocal; Lupus Erythematosus, Systemic; Rituximab; Virus Activation

2012
Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.
    Clinical and experimental dermatology, 2002, Volume: 27, Issue:7

    Topics: Administration, Oral; Autoimmune Diseases; Female; Fertility; Fetal Death; Humans; Immunosuppressive Agents; Infertility, Male; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Pregnancy; Skin Diseases

2002
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
    Current opinion in rheumatology, 2003, Volume: 15, Issue:3

    Topics: Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rheumatic Diseases; Severity of Illness Index; Sirolimus; Tacrolimus; Transplants; Treatment Outcome

2003
The broadening use of leflunomide in clinical practice.
    Hospital medicine (London, England : 1998), 2004, Volume: 65, Issue:12

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide

2004
Effects of leflunomide on immune responses and models of inflammation.
    Springer seminars in immunopathology, 1993, Volume: 14, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Autoimmune Diseases; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Graft Rejection; Humans; Immunity, Cellular; Immunosuppressive Agents; Inflammation; Isoxazoles; Leflunomide; Mice; Protein-Tyrosine Kinases; Rats

1993
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
    Current opinion in immunology, 1996, Volume: 8, Issue:5

    Topics: Animals; Autoimmune Diseases; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycophenolic Acid; Polyenes; Pyrimidine Nucleotides; Sirolimus; Tacrolimus; Xenobiotics

1996
Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Transplantation proceedings, 1996, Volume: 28, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Arthritis, Rheumatoid; Autoimmune Diseases; B-Lymphocytes; Clinical Trials as Topic; Disease Models, Animal; Humans; Immune Tolerance; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Mammals

1996
Leflunomide and malononitrilamides.
    The American journal of the medical sciences, 1997, Volume: 313, Issue:5

    Topics: Aniline Compounds; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Clinical Trials as Topic; Crotonates; Graft Rejection; Humans; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Molecular Structure; Nitriles; Organ Transplantation; Toluidines; Transplantation Immunology

1997
Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
    Immunopharmacology, 2000, Volume: 47, Issue:2-3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Autoimmune Diseases; Dihydroorotate Dehydrogenase; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pyrimidines; T-Lymphocytes

2000
Development of a novel drug for transplantation: current results and future perspectives.
    Transplantation proceedings, 2001, Volume: 33, Issue:3

    Topics: Alkynes; Aniline Compounds; Animals; Autoimmune Diseases; Biological Availability; Crotonates; Drug Design; Graft Rejection; Graft Survival; Graft vs Host Disease; Graft vs Host Reaction; Heart Transplantation; Humans; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Nitriles; Skin Transplantation; Toluidines; Transplantation, Homologous

2001
Leflunomide for the treatment of rheumatoid arthritis and autoimmunity.
    The American journal of the medical sciences, 2002, Volume: 323, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Autoimmune Diseases; Clinical Trials as Topic; Humans; Isoxazoles; Leflunomide

2002
[Leflunomide--a new drug for pharmacological immunomodulation].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2002, Volume: 53, Issue:5

    Topics: Animals; Autoimmune Diseases; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis; Skin Diseases

2002
Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.
    Agents and actions, 1991, Volume: 32, Issue:1-2

    Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Disease Models, Animal; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Molecular Sequence Data

1991

Other Studies

16 other study(ies) available for isoxazoles and Autoimmune Disease

ArticleYear
Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Animals; Autoimmune Diseases; Chemokines; Disease Models, Animal; Eye; Female; Gene Expression Regulation; Interferon-gamma; Interleukin-17; Isoxazoles; Leflunomide; Lymphocyte Activation; Lymphocytes; Peptide Fragments; Rats; Retina; Retinol-Binding Proteins; RNA, Messenger; Th17 Cells; Uveitis

2013
[Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2015, Volume: 51, Issue:10

    Topics: Animals; Autoimmune Diseases; Cyclosporine; Down-Regulation; Eye Proteins; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Isoxazoles; Leflunomide; Random Allocation; Rats; Rats, Inbred Lew; Retinitis; Retinol-Binding Proteins; RNA, Messenger; Th17 Cells; Uveitis

2015
Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008).
    Journal of the American Veterinary Medical Association, 2010, Feb-01, Volume: 236, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Autoimmune Diseases; Dog Diseases; Dogs; Female; Isoxazoles; Leflunomide; Male; Retrospective Studies

2010
The effects of leflunomide on CD4(+)CD25 (+)Foxp3 (+) T regulatory cells in mice receiving allogeneic bone marrow transplantation.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2012, Volume: 61, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Female; Forkhead Transcription Factors; Interleukin-2 Receptor alpha Subunit; Isoxazoles; Leflunomide; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes, Regulatory

2012
Leflunomide prevents the development of experimentally induced myasthenia gravis.
    International journal of immunopharmacology, 1995, Volume: 17, Issue:4

    Topics: Animals; Autoantibodies; Autoimmune Diseases; Female; Flow Cytometry; Immunization; Immunosuppressive Agents; Isoxazoles; Leflunomide; Myasthenia Gravis; Rats; Rats, Inbred Strains; Receptors, Cholinergic; T-Lymphocyte Subsets; Thymus Gland; Time Factors; Torpedo

1995
Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats.
    Agents and actions, 1994, Volume: 42, Issue:3-4

    Topics: Administration, Oral; Administration, Topical; Animals; Antibodies; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Eye Proteins; Freund's Adjuvant; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Retina; Uveitis

1994
In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice.
    Journal of immunology (Baltimore, Md. : 1950), 1997, Jul-01, Volume: 159, Issue:1

    Topics: Aniline Compounds; Animals; Autoimmune Diseases; Crotonates; Dihydroorotate Dehydrogenase; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymph Nodes; Lymphoproliferative Disorders; Mice; Mice, Mutant Strains; Nitriles; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pyrimidine Nucleotides; Toluidines; Uridine

1997
Prevention of the development of murine systemic lupus erythematosus (SLE)-like diseases by the malononitrilamides MNA 279 and MNA 715.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1997, Volume: 46 Suppl 2

    Topics: Aging; Alkynes; Animals; Autoimmune Diseases; Female; Immunosuppressive Agents; Isoxazoles; Kinetics; Lupus Erythematosus, Systemic; Lymph Nodes; Mice; Mice, Inbred DBA; Nitriles; Spleen; Splenomegaly

1997
Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:2

    Topics: Animals; Autoantibodies; Autoimmune Diseases; Biphenyl Compounds; Cytidine Triphosphate; Female; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphoproliferative Disorders; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Phosphorylation; Tyrosine; Uridine; Uridine Triphosphate

1997
Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.
    Transplantation, 1998, May-27, Volume: 65, Issue:10

    Topics: Animals; Autoimmune Diseases; Diabetes Mellitus; Diabetes Mellitus, Experimental; Female; Graft Rejection; Immunosuppression Therapy; Immunosuppressive Agents; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Mice; Mice, Inbred NOD; Mice, Inbred Strains; Rats; Rats, Sprague-Dawley; Recurrence; Transplantation, Heterologous

1998
Effects of leflunomide on experimental autoimmune myocarditis with special reference to the dendritic cells.
    Transplantation proceedings, 1998, Volume: 30, Issue:8

    Topics: Animals; Autoimmune Diseases; Dendritic Cells; Freund's Adjuvant; Heart; Immunosuppressive Agents; Isoxazoles; Leflunomide; Myocarditis; Myocardium; Myosins; Rats; Rats, Inbred Strains; Swine

1998
Modulation of immunoglobulin dysregulation in graft versus host-and systemic lupus erythematosus-like diseases by malononitrilamides.
    Transplantation proceedings, 1998, Volume: 30, Issue:8

    Topics: Acrylamide; Acrylamides; Alkynes; Animals; Antibody Formation; Autoantibodies; Autoimmune Diseases; Caproates; Crosses, Genetic; Female; Glomerulonephritis; Graft vs Host Disease; Immunoglobulin E; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Mutant Strains; Nitriles; Spleen; Transplantation, Homologous

1998
Leflunomide protects mice from multiple low dose streptozotocin (MLD-SZ)-induced insulitis and diabetes.
    Clinical and experimental immunology, 1999, Volume: 117, Issue:1

    Topics: Animals; Autoimmune Diseases; Blood Glucose; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Immunosuppressive Agents; Interferon-gamma; Islets of Langerhans; Isoxazoles; Leflunomide; Male; Mice; Mice, Inbred CBA; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pancreatitis; Streptozocin; T-Lymphocytes, Cytotoxic

1999
Leflunomide-mediated suppression of antiviral antibody and Tcell responses: differential restoration by uridine.
    Transplantation, 2001, Aug-27, Volume: 72, Issue:4

    Topics: Animals; Antibodies, Viral; Antibody Formation; Autoimmune Diseases; CD8-Positive T-Lymphocytes; Diabetes Mellitus; Dose-Response Relationship, Drug; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred C57BL; Mice, Transgenic; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Uridine; Vesicular stomatitis Indiana virus

2001
Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats.
    International journal of immunopharmacology, 1989, Volume: 11, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Autoimmune Diseases; Basement Membrane; Cyclosporins; Isoxazoles; Kidney Tubules; Leflunomide; Nephritis, Interstitial; Oxazoles; Rats; Rats, Inbred BN

1989
Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.
    Agents and actions, 1986, Volume: 19, Issue:5-6

    Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; Oxazoles

1986